Veraxa Biotech Holding AG's total liabilities is $290M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Veraxa Biotech Holding AG posts a total liabilities of $290M as of March 2026. That compares with $12M in the prior-year period — up 2263.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Veraxa Biotech Holding AG's total liabilities was $12M. The latest reading is $290M — a 2263.6% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.
Total Liabilities is one piece of Veraxa Biotech Holding AG's financial statement story. At $290M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for VRXA's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Veraxa Biotech Holding AG's other metric pages and overview cover the third.